Alembic Pharmaceuticals Limited has informed the Exchange about change in Management-Designated as Senior Management Personnel

APLLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.3%1-day move

₹753.00

prior close

₹759.95

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.2+0.2+0.8+1.3+2.3+4.2+2.6+4.5+4.9+2.3+0.7-2.3+10.9—

Up moveDown movePending

AI summary

Alembic Pharmaceuticals has announced that Mr. Amit Nayak, currently Vice President - Commercial Excellence, has been designated as Senior Management Personnel effective 1st May 2026. Mr. Nayak holds a PGDM from IMT Ghaziabad and a B.Tech in Pharmaceutical Sciences from ICT Mumbai. He brings 12 years of experience in commercial excellence, sales operations, digital enablement, market insights, and business development, with prior roles at J B Chemicals & Pharmaceuticals, Cipla, IMS, and EY. This is a routine designation change rather than a new hire or external appointment.

Likely market impact

This is a routine internal elevation with no immediate material impact on the company's leadership structure or governance. The appointment reflects continuity in senior management.